Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bortezomib Inhibits Expression of TGF-β1, IL-10, and CXCR4, Resulting in Decreased Survival and Migration of Cutaneous T Cell Lymphoma Cells
Tzu‐Pei Chang, Vladimir Poltoratsky, Ivana Vancurova
The Journal of Immunology (2015) Vol. 194, Iss. 6, pp. 2942-2953
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9
Richard Beatson, Virginia Tajadura‐Ortega, Daniela Achkova, et al.
Nature Immunology (2016) Vol. 17, Iss. 11, pp. 1273-1281
Open Access | Times Cited: 304
Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?
Cheng‐Liang Kuo, Ananth Ponneri Babuharisankar, Ying‐Chen Lin, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 176
Mitochondrial oxidative stress by Lon-PYCR1 maintains an immunosuppressive tumor microenvironment that promotes cancer progression and metastasis
Cheng‐Liang Kuo, Han-Yu Chou, Yi-Chieh Chiu, et al.
Cancer Letters (2020) Vol. 474, pp. 138-150
Open Access | Times Cited: 106
Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB
Jan P. Nicolay, Karin Müller‐Decker, Anne Schroeder, et al.
Blood (2016) Vol. 128, Iss. 6, pp. 805-815
Open Access | Times Cited: 78
Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside
William Damsky, Jaehyuk Choi
Current Treatment Options in Oncology (2016) Vol. 17, Iss. 7
Closed Access | Times Cited: 59
CRIg, a tissue-resident macrophage specific immune checkpoint molecule, promotes immunological tolerance in NOD mice, via a dual role in effector and regulatory T cells
Xiaomei Yuan, Bi-Huei Yang, Yi Dong, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 43
Histone Deacetylase (HDAC) Inhibition Induces IκB Kinase (IKK)-dependent Interleukin-8/CXCL8 Expression in Ovarian Cancer Cells
Himavanth R. Gatla, Yue Zou, Mohammad M. Uddin, et al.
Journal of Biological Chemistry (2017) Vol. 292, Iss. 12, pp. 5043-5054
Open Access | Times Cited: 42
Racial Differences in Immunological Landscape Modifiers Contributing to Disparity in Prostate Cancer
J. Thomas, Hina Mir, Neeraj Kapur, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1857-1857
Open Access | Times Cited: 37
The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T‐cell lymphoma
Julia Scarisbrick, M. Bagot, Pablo L. Ortiz‐Romero
British Journal of Haematology (2020) Vol. 192, Iss. 4, pp. 683-696
Open Access | Times Cited: 33
The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets
Alba Guglielmo, Corrado Zengarini, Claudio Agostinelli, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 584-584
Open Access | Times Cited: 4
Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells
Leonie De Wilt, Bartosz Kamil Sobocki, Gerrit Jansen, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 4
The proteasome inhibitor bortezomib attenuates renal fibrosis in mice via the suppression of TGF-β1
Moko Zeniya, Takayasu Mori, Naofumi Yui, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 35
Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients
Romanos Sklavenitis‐Pistofidis, Marzia Capelletti, Chia‐Jen Liu, et al.
Blood (2018) Vol. 132, Iss. 24, pp. 2608-2612
Open Access | Times Cited: 35
Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease
Lisa Argnani, Alessandro Broccoli, Pier Luigi Zinzani
Cancer Treatment Reviews (2017) Vol. 61, pp. 61-69
Closed Access | Times Cited: 34
Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer
Ok-Seon Kwon, Haeseung Lee, Hyeon-Joon Kong, et al.
Oncogene (2020) Vol. 39, Iss. 23, pp. 4567-4580
Open Access | Times Cited: 32
An Update on Molecular Biology of Cutaneous T Cell Lymphoma
Ritika Walia, Cecilia C.S. Yeung
Frontiers in Oncology (2020) Vol. 9
Open Access | Times Cited: 30
The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas
Liang Lin, Gabriele Roccuzzo, Yuliya Yakymiv, et al.
Cells (2025) Vol. 14, Iss. 4, pp. 309-309
Open Access
Unveiling the Role of the Cellular Tumor Microenvironment and the Therapeutic Targets it Provides in Cutaneous T-Cell Lymphoma
Nikolaos A. Chinas, Stella Kaliampou, Vasiliki Nikolaou
Current Oncology Reports (2025)
Open Access
An Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs
Junjiang Sun, Wenwei Shao, Xiaojing Chen, et al.
Molecular Therapy — Methods & Clinical Development (2018) Vol. 10, pp. 257-267
Open Access | Times Cited: 30
Preclinical Evidence for Targeting PI3K/mTOR Signaling with Dual-Inhibitors as a Therapeutic Strategy against Cutaneous T-Cell Lymphoma
Antonella Bresin, Cristina Cristofoletti, Elisabetta Caprini, et al.
Journal of Investigative Dermatology (2019) Vol. 140, Iss. 5, pp. 1045-1053.e6
Open Access | Times Cited: 27
Skin infiltrating NK cells in cutaneous T-cell lymphoma are increased in number and display phenotypic alterations partially driven by the tumor
Andrea Scheffschick, Julia Nenonen, Mengmeng Xiang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
IKK inhibition increases bortezomib effectiveness in ovarian cancer
Bipradeb Singha, Himavanth R. Gatla, Sai Phyo, et al.
Oncotarget (2015) Vol. 6, Iss. 28, pp. 26347-26358
Open Access | Times Cited: 28
Apelin inhibited epithelial−mesenchymal transition of podocytes in diabetic mice through downregulating immunoproteasome subunits β5i
Jiming Yin, Yangjia Wang, Jing Chang, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 10
Open Access | Times Cited: 21
Combined inhibition of Bcl-2 and NFκB synergistically induces cell death in cutaneous T-cell lymphoma
Tabea C. Froehlich, Karin Müller‐Decker, Jana D. Braun, et al.
Blood (2019) Vol. 134, Iss. 5, pp. 445-455
Open Access | Times Cited: 21
A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes
Ping Zhao, Mengyuan Ji, Ying Fang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top